Search for: "Pfizer Pharmaceutic, Inc."
Results 461 - 480
of 667
Sorted by Relevance
|
Sort by Date
17 Feb 2012, 11:29 am
Pfizer, Inc., 381 F. [read post]
29 Feb 2008, 8:00 am
: (creativecommons.org)Pharma & BiotechPharma & Biotech - GeneralScience Commons news: A commons-sense approach to winning the drug discovery lottery: (creativecommons.org),India: Hindu Business Line reports on why pharma companies are pushing for tax incentives: (Spicy IP), India: J Mitra gets injunction against Span Diagnostics in patent dispute before Delhi High Court over device used in detection of Hep C: (Generic Pharmaceuticals & IP), India: Patent Office… [read post]
11 Nov 2010, 12:54 pm
Pfizer Inc., 2009 WL 3230611, at *8 (W.D. [read post]
27 Dec 2007, 7:09 am
Pfizer, Inc., 490 F. [read post]
1 Mar 2017, 3:08 pm
The plaintiffs originally filed each of the subject eight lawsuits in California state court against the defendants Pfizer, Inc. and McKesson Corp., alleging that a pharmaceutical product, Lipitor, caused them to develop Type II diabetes and that, among other things, the defendants did not properly disclose the risks associated with Lipitor. [read post]
23 Oct 2008, 10:31 am
" According to the AP (10/22, Tanner), other "drugs under examination are Genentech Inc.'s psoriasis drug Raptiva (efalizumab), which just last week the Food and Drug Administration (FDA) warned may contribute to a life-threatening brain illness and infections; and Exubera, an inhaled insulin product, linked with lung cancer risks," which "Pfizer Inc. stopped selling...last year. [read post]
7 Jun 2011, 8:51 am
Pfizer, Inc., 196 F. [read post]
15 Nov 2013, 11:34 am
Pfizer, Inc., 914 F. [read post]
19 Apr 2022, 5:05 am
Reg. 35952, 35958 (1991), See also OIG Compliance Program Guidance for Pharmaceutical Manufacturers, 66 Fed. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
31 Oct 2013, 5:00 am
Pfizer Inc., 249 F.R.D. 248, 254-55 (E.D. [read post]
15 Aug 2014, 12:54 pm
Spending a couple of pages distinguishing Pfizer, Inc. v. [read post]
25 Apr 2011, 3:24 am
’” Bloomberg News reported, “Pfizer Inc. [read post]
25 Apr 2011, 3:19 am
(PFE), Johnson & Johnson (JNJ) and Endo Pharmaceuticals Holdings Inc. [read post]
30 Aug 2011, 10:07 pm
Notes from around the patently-o-sphere: Kevin Noonan writes that “the decision provides a contrast between how the Court views chemical obviousness for pharmaceutical formulations today, and the views contained in the Court's opinion in Pfizer, Inc. v. [read post]
7 Sep 2011, 4:22 am
: Pfizer v Teva (Property, intangible) [read post]
6 Mar 2014, 12:41 pm
Pfizer, Inc., 490 F. [read post]
21 Jun 2012, 11:46 am
Pfizer, Inc.47. [read post]
28 Dec 2023, 12:56 pm
Examples Of False Claims Act Cases Involving Copay Waivers In 2018, Pharmaceutical company Actelion Pharmaceuticals US, Inc agreed to pay $360 million to resolve claims that it illegally used a foundation as a conduit to pay the co-pays of thousands of Medicare patients taking Actelion’s pulmonary arterial hypertension drugs, in violation of the False Claims Act. [read post]
8 Oct 2015, 5:00 am
Caraco Pharmaceutical, Inc., 670 F. [read post]
